These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34679551)

  • 1. Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets.
    Maggio I; Franceschi E; Di Nunno V; Gatto L; Tosoni A; Angelini D; Bartolini S; Lodi R; Brandes AA
    Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular alterations in meningioma: prognostic and therapeutic perspectives.
    Birzu C; Peyre M; Sahm F
    Curr Opin Oncol; 2020 Nov; 32(6):613-622. PubMed ID: 32890025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new amplicon-based gene panel for next generation sequencing characterization of meningiomas.
    Mawrin C; Koch R; Waldt N; Sandalcioglu IE; Braunsdorf WEK; Warnke JP; Goehre F; Meisel HJ; Ewald C; Neyazi S; Schüller U; Kirches E
    Brain Pathol; 2022 Mar; 32(2):e13046. PubMed ID: 35213080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of genetic alterations and methylation classes in meningioma.
    Berghoff AS; Hielscher T; Ricken G; Furtner J; Schrimpf D; Widhalm G; Rajky U; Marosi C; Hainfellner JA; von Deimling A; Sahm F; Preusser M
    Brain Pathol; 2022 Mar; 32(2):e12970. PubMed ID: 35213082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningioma: Molecular Updates from the 2021 WHO Classification of CNS Tumors and Imaging Correlates.
    Soni N; Ora M; Bathla G; Szekeres D; Desai A; Pillai J; Agarwal A
    AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38844366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningioma: current updates on genetics, classification, and mouse modeling.
    Szulzewsky F; Thirimanne HN; Holland EC
    Ups J Med Sci; 2024; 129():. PubMed ID: 38571886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic landscape of meningioma.
    Yuzawa S; Nishihara H; Tanaka S
    Brain Tumor Pathol; 2016 Oct; 33(4):237-247. PubMed ID: 27624470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Landscape of Meningiomas.
    Wang JZ; Nassiri F; Mawrin C; Zadeh G
    Adv Exp Med Biol; 2023; 1416():137-158. PubMed ID: 37432625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific gene expression signatures of low grade meningiomas.
    Tsitsikov EN; Hameed S; Tavakol SA; Stephens TM; Tsytsykova AV; Garman L; Bi WL; Dunn IF
    Front Oncol; 2023; 13():1126550. PubMed ID: 36937440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
    Abedalthagafi M; Bi WL; Aizer AA; Merrill PH; Brewster R; Agarwalla PK; Listewnik ML; Dias-Santagata D; Thorner AR; Van Hummelen P; Brastianos PK; Reardon DA; Wen PY; Al-Mefty O; Ramkissoon SH; Folkerth RD; Ligon KL; Ligon AH; Alexander BM; Dunn IF; Beroukhim R; Santagata S
    Neuro Oncol; 2016 May; 18(5):649-55. PubMed ID: 26826201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Discrepancy Between Standard Histologic WHO Grading of Meningioma and Molecular Profile: A Single Institution Series.
    Roehrkasse AM; Peterson JEG; Fung KM; Pelargos PE; Dunn IF
    Front Oncol; 2022; 12():846232. PubMed ID: 35299730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meningioma].
    Sasaki H
    No Shinkei Geka; 2023 Sep; 51(5):829-836. PubMed ID: 37743334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Classification and Molecular Diagnosis of Benign Brain Tumors].
    Yoshimoto K
    No Shinkei Geka; 2023 Sep; 51(5):771-777. PubMed ID: 37743328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.
    Yesilöz Ü; Kirches E; Hartmann C; Scholz J; Kropf S; Sahm F; Nakamura M; Mawrin C
    Neuro Oncol; 2017 Aug; 19(8):1088-1096. PubMed ID: 28482067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade meningiomas: biology and implications.
    Bi WL; Prabhu VC; Dunn IF
    Neurosurg Focus; 2018 Apr; 44(4):E2. PubMed ID: 29606053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups.
    Singh J; Sharma R; Shukla N; Narwal P; Katiyar A; Mahajan S; Sahu S; Garg A; Sharma MC; Suri A; Sarkar C; Suri V
    J Neurooncol; 2023 Jan; 161(2):339-356. PubMed ID: 36564673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Invasion and Trends in Molecular Research on Meningioma.
    Go KO; Kim YZ
    Brain Tumor Res Treat; 2023 Jan; 11(1):47-58. PubMed ID: 36762808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.
    Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
    J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of meningiomas: Building the roadmap towards personalized therapy.
    Peyre M; Kalamarides M
    Neurochirurgie; 2018 Mar; 64(1):22-28. PubMed ID: 25245924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
    Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C
    Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.